Routes of Human Rabies Infection and Prophylaxis as Methods of Prevention
DOI:
https://doi.org/10.12775/QS.2026.53.69829Keywords
rabies, human rabies, pre-exposure prophylaxis, prophylaxisAbstract
The rabies virus is responsible for one of the most severe diseases transmitted from animals to humans. Rabies is associated with an almost 100% case-fatality rate once clinical symptoms develop. The aim of this study is to present the principal routes of rabies virus transmission to humans and to discuss strategies for limiting viral spread through preventive measures, based on the available literature concerning the pathogenesis, epidemiology, and prophylactic methods applied in both animals and humans.
The primary route of transmission to humans is a bite from an infected animal. However, other, less common routes of infection are also possible, including contact of secretions from an infected animal with mucous membranes or damaged skin. Extremely rare cases of transmission have also been reported through aerosol exposure or through organ transplantation from an infected donor.
In Europe, wild animals constitute the main reservoir of the rabies virus, with particular emphasis on foxes, highlighting the critical role of oral vaccination programs targeting these species. Vaccination of domestic animals, as well as pre-exposure and post-exposure prophylaxis in humans, also remain essential components of rabies prevention. A multidisciplinary approach to rabies control, integrating the efforts of veterinary and medical services through infection control in animal populations, improved access to vaccines and rabies immunoglobulin, and increased public awareness regarding the disease, its transmission routes, and preventive measures, may ultimately contribute to the complete elimination of human rabies in the future.
References
[1] Kruse H., Kirkemo A.M., Handeland K.: Wildlife as source of zoonotic infections. Emerg. Infect. Dis. 2004, 10, 2067-2072.
[2] World Health Organization. Update on elimination of human deaths from dog-mediated rabies. Geneva: WHO; 2024. Available from: https://who-track.phmovement.org/update-elimination-human-deaths-dog-mediated-rabies
[3] OIE: Report of the meeting of the OIE Working Group on wildlife diseases 9-11 February, Paris OIE, 2003.
[4] Pötzch J., Kliemt A., Klöss D., Schröder R., Műller W.: Rabies in Europe-trends and development. Dev. Biol. 2006, 125, 59-68.
[5] Rupprecht C.E., Smith J.S., Fekadu M., Childs J.E.: The ascension of wildlife rabies: a cause for public heath concern or intervention. Emerg. Infect. Dis. 1995, 1, 107-114.
[6] Artois M, Aubert M, Stahl P. Spatial organization of the red fox (Vulpes vulpes L., 1758) in a rabies enzootic area in Lorraine. Rev Ecol (Terre Vie). 1990;45:113–134. Available from: https://www.researchgate.net/publication/357926927_Organisation_spatiale_du_renard_roux_vulpes_vulpes_L_1758_en_zone_d'enzootie_de_rage_en_Lorraine
[7] Gliński Z, Kostro K. Rabies and Lyme disease in game animals as a threat to humans. Magazyn Weterynaryjny. 2018 Mar 12. Available from: https://magwet.pl/22285,wscieklizna-i-borelioza-zwierzat-lownych-zagrozeniem-dla-czlowieka
[8] Fiszdon K, Boruta A. Analysis of dog biting incidents. Part II. Who are the victims? Życie Weterynaryjne. 2013;88(3):213–217. Available from: https://www.researchgate.net/profile/Boruta-Agnieszka/publication/331277101_Analysis_of_dog_biting_incidents_Part_II_Who_are_the_victims/links/5c6fdfd2a6fdcc47159205b2/Analysis-of-dog-biting-incidents-Part-II-Who-are-the-victims.pdf
[9] Constantine DG. Rabies transmission by air in bat caves. Public Health Service Publication No. 1617, 1967, Atlanta Centers for Disease Control and Prevention.
[10] Johnson N et al. Airborne transmission of lyssaviruses. J Med Microbiol. 2006;55(6):785–790.
[11] Winkler WG et al. Airborne rabies transmission in a laboratory worker. JAMA. 1973;226:1219–1221.
[12] Turmelle A.S., Jackso F.R., Green D., McCracken G.F., Rupprecht C.: Host immunity to repeated rabies virus infection in big brown bat. J. Gen. Virol. 2010, 91, 2360–2366.
[13] Aguèmon CT et al. Rabies transmission risks during peripartum –Two cases and a review of the literature. Vaccine. 201634(15):1752–1757.
[14] Rupprecht CE et al. Current Status and Development of Vaccines and Other Biologics for Human Rabies Prevention. Expert Rev Vaccines. 2016;15(6):731–749.
[15] WHO Expert Consultation on Rabies, third report: WHO Technical Series Report No. 1012, Geneva, 2018 (ISBN 978-92-4-121021-8).
[16] Mól H. Rabies in animals in 2007 in the context of fox vaccination in Poland in 1999–2007. Życie Weterynaryjne. 2008;83:615–618.
[17] Frymus T. Rabies should not be forgotten. Magazyn Weterynaryjny. 2021 Sep 7. Available from: https://magwet.pl/36622,wscieklizna-nie-daje-o-sobie-zapomniec
[18] Act of 5 December 2008 on the Prevention and Control of Infections and Infectious Diseases in Humans. Journal of Laws of the Republic of Poland (Dz.U.) 2008, No. 234, item 1570.
[19] Fiszdon, K., Boruta, A. Analysis of dog bite cases. Part I. Which dogs bite? Życie Weterynaryjne, 2012, 87(12), 1022–1026. Available at: https://zycie-weterynaryjne.pl/wp-content/uploads/2023/12/ZW-2012-12-07.pdf
[20] Rupprecht CE, Shlim DR. Rabies. In: Brunette GW, editor. CDC Health Information for International Travel (Yellow Book). Atlanta: Centers for Disease Control and Prevention; 2014. Available from: https://wwwnc.cdc.gov/travel/yellowbook/2016/chapter-3-infectious-diseases-related-to-travel/rabies
[21] Rupprecht C.E., Briggs D., Brown C.M. i wsp.: Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies: recommendations of the advisory committee on immunization practices. MMWR Recomm. Rep., 2010; 59: 1-9.
[22] Rupprecht CE et al. Rabies vaccine. In: Plotkin S, Orenstein W, Offit P, Edwards K, editors. Plotkin’s Vaccines. 7th ed. Philadelphia: Elsevier; 2018. p. 918–949.
[23] World Health Organization. Rabies vaccines: WHO position paper – April 2018. Weekly Epidemiological Record. 2018;93(16):201–220. Available from: https://iris.who.int/server/api/core/bitstreams/dc122df7-62bd-4ca4-bbb0-31c74cdc92d8/content
[24] World Health Organization. Rabies Working Group report: SAGE meeting, October 2017. Geneva: World Health Organization; 2017. Available from: http://www.who.int/immunization/sage/meetings/2017/october/1_Background_paper_WG_RABIES_final.pdf?ua=1
[25] Both L et al. Passive immunity in the prevention of rabies. Lancet Infect Dis. 2012; 12(5):397–407.
[26] Centers for Disease Control and Prevention (CDC). Rabies biologics. Atlanta: CDC; 2025. Available from: https://www.cdc.gov/rabies/hcp/clinical-care/biologics.html
[27] Médecins Sans Frontières (MSF). Human rabies immunoglobulin (HRIG). MSF Medical Guidelines. Available from: https://medicalguidelines.msf.org/en/viewport/EssDr/english/human-rabies-immunoglobulin-hrig-16688380.html
[28] UK Health Security Agency. Rabies: Human rabies immunoglobulin (HRIG). GOV.UK. Updated 17 September 2025. Available from: https://www.gov.uk/government/publications/immunoglobulin-when-to-use/rabies-human-rabies-immunoglobulin-hrig--2
[29] Crowcroft NS et al. The prevention and management of rabies. BMJ. 2015 Jan 14; 350:g7827.
[30] de Martino M. Dismantling the Taboo against Vaccines in Pregnancy. Int J Mol Sci. 2016;17(6).
[31] Dixit R et al. Benefits of using heterologous polyclonal antibodies and potential applications to new and undertreated infectious pathogens. Vaccine. 2016; 34(9):1152–1161.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Kacper Dąbrowski, Natalia Leśniewska, Bartłomiej Szymulewicz , Jakub Łukaszewicz , Małgorzata Niewęgłowska , Paulina Walczak , Aleksandra Bender , Katarzyna Widomska , Mateusz Bernad , Oliwia Krazińska , Magdalena Gałach

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 97
Number of citations: 0